Literature DB >> 352937

Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates.

B H Minshew, J Jorgensen, G W Counts, S Falkow.   

Abstract

One hundred forty-two strains of Escherichia coli isolated from extraintestinal infections were examined for colicin V (ColV) and hemolysin (Hly) production. For comparison, 20 strains isolated from the feces of normal individuals and 12 enteropathogenic strains of E. coli were tested for these properties. Thirty-five to 59% of extraintestinal isolates were Hly+, but only one fecal strain was Hly+. Colicin V biosynthesis was found for 12% of blood culture isolates, 7% of urine culture isolates and 16% of the strains from other extraintestinal infections. None of the fecal isolates was ColV+. Selected strains were tested for virulence in 13-day-old chicken embryos; these same strains were tested for their ability to hemagglutinate chicken or human erythrocytes. Of 22 extraintestinal isolates, 13 (59%) killed greater than or equal to 60% of the embryos within 72 h. Only one of eight normal fecal isolates and two of three enteropathogenic strains tested were virulent. About 80% of the virulent strains were Hly+. The most striking finding, however, was the hemagglutination of human erythrocytes by virulent extraintestinal isolates. It seems possible that the hemagglutination property reflects a specific common adherence factor.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352937      PMCID: PMC421548          DOI: 10.1128/iai.20.1.50-54.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Properties of strains of Escherichia coli isolated from a variety of sources.

Authors:  E M Cooke; S P Ewins
Journal:  J Med Microbiol       Date:  1975-02       Impact factor: 2.472

2.  The haemolysins of Escherichia coli.

Authors:  H W SMITH
Journal:  J Pathol Bacteriol       Date:  1963-01

3.  Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans.

Authors:  F J Skerman; S B Formal; S Falkow
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

4.  The transmissible nature of the genetic factor in Escherichia coli that controls haemolysin production.

Authors:  H W Smith; S Halls
Journal:  J Gen Microbiol       Date:  1967-04

5.  Pili as a mediator of the attachment of gonococci to human erythrocytes.

Authors:  T M Buchanan; W A Pearce
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

6.  Further observations on the association of the colicine V plasmid of Escherichia coli with pathogenicity and with survival in the alimentary tract.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1976-02

7.  Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-11       Impact factor: 2.472

8.  Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons.

Authors:  E M Cooke
Journal:  J Pathol Bacteriol       Date:  1968-01

9.  Virulence of Escherichia coli strains for chick embryos.

Authors:  C J Powell; R A Finkelstein
Journal:  J Bacteriol       Date:  1966-04       Impact factor: 3.490

10.  Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection.

Authors:  C S Edén; L A Hanson; U Jodal; U Lindberg; A S Akerlund
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

View more
  97 in total

1.  New fimbrial antigen F165 from Escherichia coli serogroup O115 strains isolated from piglets with diarrhea.

Authors:  J M Fairbrother; S Larivière; R Lallier
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

2.  Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination.

Authors:  J F van den Bosch; P Postma; P A Koopman; J de Graaff; D M MacLaren; D G van Brenk; P A Guinée
Journal:  J Hyg (Lond)       Date:  1982-06

3.  Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans.

Authors:  A Cravioto; S M Scotland; B Rowe
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Genetics of hemolysin of Escherichia coli.

Authors:  S I Hull; R A Hull; B H Minshew; S Falkow
Journal:  J Bacteriol       Date:  1982-08       Impact factor: 3.490

6.  Colonization antigens and haemagglutination patterns of human Escherichia coli.

Authors:  J Blanco; E A González; R Anadón
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

7.  Occurrence of P-fimbriated Escherichia coli in patients with bacteremia.

Authors:  A Brauner; M Leissner; B Wretlind; I Julander; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

8.  Cloning and characterization of hemolytic genes from Helicobacter pylori.

Authors:  E S Drazek; A Dubois; R K Holmes; D Kersulyte; N S Akopyants; D E Berg; R L Warren
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes.

Authors:  O V Gadeberg; I Orskov
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.